Anxiety in Cataract Patients Using Preoperative Music Therapy

December 8, 2025 updated by: Guangzhou First People's Hospital

Research on Interventions for Anxiety in Cataract Patients Using Preoperative Music Therapy

The researchers designed this study to investigate whether implementing preoperative music intervention in cataract surgery can reduce perioperative anxiety, alleviate postoperative pain, and enhance patient satisfaction with the surgical procedure.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

This is a single-center, randomized controlled single-blind trial. Computer-generated randomization will be used to allocate patients into two groups: a control group (without music therapy) and music therapy group A (listening to music preoperatively). Patient anxiety levels, pain intensity, satisfaction with the surgical procedure, and degree of cooperation during surgery will be assessed through preoperative and postoperative questionnaires and salivary cortisol measurements. Blood pressure and heart rate will be monitored both preoperatively and intraoperatively.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangzhou
      • Guangzhou, Guangzhou, China, 510180
        • Guangzhou First People's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Meets the diagnostic criteria for cataract
  • Age ≤ 90 years
  • Scheduled for phacoemulsification with IOL implantation under topical anesthesia at the Ophthalmology Department of Guangzhou First People's Hospital
  • Voluntarily participates and provides signed informed consent

Exclusion Criteria:

  • Requires complex and prolonged surgery, such as:

    1. Shallow anterior chamber with risk of glaucoma
    2. Advanced cataracts with hard nuclei
    3. Small pupils
  • Has hearing impairment or communication difficulties
  • Shows significant anxiety/depression tendencies or has a history of mental illness with prior/current use of sedatives
  • Refuses to participate, or has difficulty understanding/answering questionnaires, or has cognitive impairments
  • Uses medications that may affect cortisol and cardiovascular reactivity, including:

    1. Oral contraceptives
    2. Thyroid drugs
    3. Steroids
    4. Psychotropic drugs
  • Diagnosed with autoimmune diseases (e.g., Sjögren's syndrome) or oral diseases with inflammation/active lesions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Experimental:Music therapy
The patient listened to the selected music through headphones fifteen minutes before the operation.
Patients listen to the selected music through headphones fifteen minutes before the operation.
Placebo Comparator: Control group (without music therapy)
Patients wore headphones 15 minutes before the operation, but no music was played.
Patients wore headphones 15 minutes before the operation, but no music was played.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Salivary Cortisol Levels
Time Frame: Operational day
Saliva samples were collected at admission and 15 minutes postoperatively using Salivette tubes, centrifuged, and stored at -80°C. Cortisol concentrations were measured via ELISA using the R&D Systems Cortisol Assay Kit (Cat. No. KGE008B)
Operational day
SATI simplified questionnaire
Time Frame: Operational day
Anxiety was assessed using the SATI simplified questionnaire (6 items, Likert scale 1-4, 1 = none, 4 = severe)
Operational day
Visual Analog Scale
Time Frame: Operational day
Visual Analog Scale (VAS, 0-10, 0 = no anxiety, 10 = extreme anxiety)
Operational day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood pressure
Time Frame: Operational day
Blood pressure is continuously monitored and recorded in mmHg in the operating room
Operational day
Intraoperative Pain
Time Frame: Operational day
Pain intensity was quantified using a VAS (0-10, 0 = no pain, 10 = worst pain)
Operational day
Heart rate
Time Frame: Operational day
Heart rate is continuously monitored and recorded in beats per minute in the operating room
Operational day
Respiratory rate
Time Frame: Operational day
Respiratory rate is continuously monitored and recorded in breaths per minute in the operating room
Operational day
The patient's cooperation
Time Frame: Operational day
The patient's cooperation was assessed by the operating surgeon on a 4-point scale (4=Very Cooperative, 1=Poorly Cooperative).
Operational day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yuehong Zhang, Guangzhou First People's Hosipital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 31, 2025

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

July 31, 2027

Study Registration Dates

First Submitted

November 18, 2025

First Submitted That Met QC Criteria

December 8, 2025

First Posted (Actual)

December 22, 2025

Study Record Updates

Last Update Posted (Actual)

December 22, 2025

Last Update Submitted That Met QC Criteria

December 8, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • k-2025-073-01

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cataract

Clinical Trials on Music intervention

Subscribe